Flu vaccine projections
Executive Summary
Centers for Disease Control and Prevention estimate the potential number of flu vaccines for the 2007/2008 season will reach 132 million doses - a significant increase from the 120 million produced last year, a CDC spokesman said. Specific dose estimates are as follows: Sanofi Pasteur's Fluzone, 50 million; Novartis' Fluvirin, 40 million; GlaxoSmithKline's Fluarix, 30 to 35 million; and MedImmune's FluMist, 7 million. Another source of flu vaccine in Australia may make the total projection "substantially" higher for the year, the spokesman said...
You may also be interested in...
UCB Aims To Tailor Myasthenia Gravis Therapy Options To Patients
Belgium’s UCB Pharma is expecting progress with new candidates for myasthenia gravis, psoriasis and osteoporosis this year.
EU Industry Decries Price Cuts And Clawbacks
A detailed report published by Medicines for Europe setting out policies affecting the off-patent industry across 22 European countries demonstrates the urgent need for pricing and reimbursement and procurement reforms, the association insists.
Novartis Teams Up With CureVac To Make COVID-19 Vaccine
The Swiss major, which is already signed up to help produce Pfizer and BioNTech's COVID-19 vaccine, is offering its services to CureVac to produce its mRNA vaccine.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: